Switching to mianserin (60 mg/d) vs continuing on current antidepressant (fluoxetine 20 mg/d)
Leaving the study early · treatment‐resistant depression in adults
Switching to mianserin (60 mg/d) showed no clear difference in dropouts compared with continuing on current antidepressant (fluoxetine 20 mg/d) (low certainty).
1 finding from 1 review
- Pharmacological interventions for treatment‐resistant depression in adults 2019 · Cochrane Headline outcomes onlyRR 2.08 [0.94, 4.59]1 study · 72 participantsLow